Cargando…

Intranasal esketamine and the dawn of precision psychiatry

Detalles Bibliográficos
Autores principales:	Watts, Devon, Garcia, Frederico D., Lacerda, Acioly L.T., Mari, Jair de J., Quarantini, Lucas C., Kapczinski, Flávio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041972/ https://www.ncbi.nlm.nih.gov/pubmed/34320126 http://dx.doi.org/10.1590/1516-4446-2021-0031

Ejemplares similares

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
por: Correia-Melo, Fernanda S, et al.
Publicado: (2017)

DAWN OF PRECISION IN PSYCHIATRY
por: Sethi, B. B.
Publicado: (1981)

Stigmatized individuals: a case for precision ethics
por: Watts, Devon, et al.
Publicado: (2023)

Precision Psychiatry: The Future Is Now
por: Passos, Ives Cavalcante, et al.
Publicado: (2021)

Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial
por: Caliman-Fontes, Ana Teresa, et al.
Publicado: (2023)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
por: Del Sant, Lorena Catarina, et al.
Publicado: (2022)

The Dawn of Australian Psychiatry
por: Leigh, Denis
Publicado: (1970)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Intranasal Esketamine administration in catatonia: a case report.
por: Romay, J., et al.
Publicado: (2023)

Dissociating the Clinical Role and Economic Value of Intranasal Esketamine
por: Dadiomov, David
Publicado: (2020)

Dawning precision treatment for gastric cancer: The latest biomarkers
por: Sun, Keran, et al.
Publicado: (2021)

Precision psychiatry
por: Serretti, Alessandro
Publicado: (2021)

Intranasal esketamine use in bipolar disorder: A case report
por: Skriptshak, Courtney, et al.
Publicado: (2021)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
por: Pepe, Maria, et al.
Publicado: (2023)

Psychiatry and the internet: a new dawn?
por: Skuse, David
Publicado: (2004)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
por: Hernandez Huerta, D., et al.
Publicado: (2022)

Predicting criminal and violent outcomes in psychiatry: a meta-analysis of diagnostic accuracy
por: Watts, Devon, et al.
Publicado: (2022)

The antidepressant effect and safety of non-intranasal esketamine: A systematic review
por: Smith-Apeldoorn, Sanne Y, et al.
Publicado: (2022)

The Dawn of Litholapaxy
Publicado: (1900)

The Dawn of Modern Pathology
por: Ferraz de Campos, Fernando Peixoto
Publicado: (2016)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
por: Carter, Maximilian, et al.
Publicado: (2022)

Median effective dose of esketamine for intranasal premedication in children with congenital heart disease
por: Huang, Jiajia, et al.
Publicado: (2023)

Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
por: Correia-Melo, Fernanda S., et al.
Publicado: (2018)

A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial
por: Lu, Xinlei, et al.
Publicado: (2022)

Fostering precision psychiatry through bioinformatics
por: Fernandes, Brisa S., et al.
Publicado: (2021)

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021)

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression
por: Skala, Katrin, et al.
Publicado: (2023)

Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
por: Mercado-Rodríguez, A., et al.
Publicado: (2023)

Psychiatry is the flagship of personalized and precision medicine: proposing an epistemic horizon to biological psychiatry
por: Joober, Ridha
Publicado: (2022)

Dawn of Precision Medicine in Psoriatic Arthritis
por: Miyagawa, Ippei, et al.
Publicado: (2022)

A new dawn in ICUrology
por: Park, Kwangsung
Publicado: (2017)

The Dawn of a Health Age
Publicado: (1911)

At the Dawn of Applied DNA Nanotechnology
por: Linko, Veikko
Publicado: (2020)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021)

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
por: Dijkstra, Francis M, et al.
Publicado: (2022)

ERAS – The dawn of a new era!
por: Gopinath, Ramachandran, et al.
Publicado: (2019)

Pacific Eclipse: Before the corona dawn
por: Kelleher, Anthony D.
Publicado: (2022)

Dr. Dawn K. Smith, in memoriam
por: Kourtis, Athena P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rp7u63ell4ta2ifpemkm0h5hoi